The odds ratio estimates for all cancer combined was 1.07 (95% CI, 0.83-1.37) for calcium antagonist users relative to nonusers. Article PubMed CAS Google Scholar Olsen JH, Toft Sorensen HT, Friis S, et al.: Cancer risk in users of calcium channel blockers. Hypertension 1997, 29:1091...